ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Charmacy Pharmaceutical Co., Ltd. ?
1
High Debt company with Weak Long Term Fundamental Strength
- Poor long term growth as Net Sales has grown by an annual rate of 2.53% and Operating profit at 12.79% over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at times
2
Negative results in Dec 24
- OPERATING CASH FLOW(Y) Lowest at HKD 13.68 MM
- DEBTORS TURNOVER RATIO(HY) Lowest at 3.86%
- NET SALES(Q) Lowest at HKD 2,259.72 MM
3
With ROE of 8.78%, it has a Very Expensive valuation with a 0.96 Price to Book Value
- Over the past year, while the stock has generated a return of -43.00%, its profits have risen by 1.6% ; the PEG ratio of the company is 7
4
Below par performance in long term as well as near term
- Along with generating -43.00% returns in the last 1 year, the stock has also underperformed Hang Seng Hong Kong in the last 3 years, 1 year and 3 months
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Charmacy Pharmaceutical Co., Ltd. for you?
Low Risk, Low Return
Absolute
Risk Adjusted
Volatility
Charmacy Pharmaceutical Co., Ltd.
-43.0%
-1.16
34.78%
Hang Seng Hong Kong
30.06%
1.09
25.93%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
2.53%
EBIT Growth (5y)
12.79%
EBIT to Interest (avg)
2.11
Debt to EBITDA (avg)
8.12
Net Debt to Equity (avg)
2.02
Sales to Capital Employed (avg)
1.95
Tax Ratio
25.15%
Dividend Payout Ratio
91.41%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
6.12%
ROE (avg)
8.99%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
11
Industry P/E
Price to Book Value
0.96
EV to EBIT
13.37
EV to EBITDA
10.56
EV to Capital Employed
0.99
EV to Sales
0.41
PEG Ratio
6.97
Dividend Yield
7.91%
ROCE (Latest)
7.37%
ROE (Latest)
8.78%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Bearish
No Trend
OBV
Mildly Bullish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend
Not enough Data to analyse Financial Trend
Not enough Data to analyse Financial Trend
Here's what is working for Charmacy Pharmaceutical Co., Ltd.
Raw Material Cost
Fallen by -18.32% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Depreciation
Highest at HKD 19.96 MM
in the last five periodsMOJO Watch
The expenditure on assets done by the company may have gone into operation
Depreciation (HKD MM)
Here's what is not working for Charmacy Pharmaceutical Co., Ltd.
Operating Cash Flow
Lowest at HKD 13.68 MM and Fallen
In each year in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (HKD MM)
Net Sales
Lowest at HKD 2,259.72 MM
in the last five periodsMOJO Watch
Near term sales trend is negative
Net Sales (HKD MM)
Debtors Turnover Ratio
Lowest at 3.86%
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling Debtors has slowed
Debtors Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
